These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 32538502

  • 1. Clostridium difficile infection and risk of Parkinson's disease: a Swedish population-based cohort study.
    Kang X, Ploner A, Ludvigsson JF, Williams DM, Larsson H, Pedersen NL, Wirdefeldt K.
    Eur J Neurol; 2020 Nov; 27(11):2134-2141. PubMed ID: 32538502
    [Abstract] [Full Text] [Related]

  • 2. Incidence of and risk factors for recurrent Clostridioidesdifficile infection in Japan using a claims database: A retrospective cohort study.
    Mikamo H, Kondo T, Okuyama K, Marcella SW, Ruzicka DJ.
    Anaerobe; 2020 Feb; 61():102139. PubMed ID: 31830597
    [Abstract] [Full Text] [Related]

  • 3. Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.
    Mamic P, Heidenreich PA, Hedlin H, Tennakoon L, Staudenmayer KL.
    J Card Fail; 2016 Nov; 22(11):891-900. PubMed ID: 27317844
    [Abstract] [Full Text] [Related]

  • 4. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V, Dumyati G, Brown J, Wijngaarden E.
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [Abstract] [Full Text] [Related]

  • 5. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
    Singh H, Nugent Z, Yu BN, Lix LM, Targownik LE, Bernstein CN.
    Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
    [Abstract] [Full Text] [Related]

  • 6. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Li Y, Xu H, Xu T, Xiao M, Tang H, Wu D, Tan B, Li J, Yang H, Lv H, Xu Y, Qian J.
    Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
    [Abstract] [Full Text] [Related]

  • 7. Risk of Clostridium difficile Infection in Patients With Celiac Disease: A Population-Based Study.
    Lebwohl B, Nobel YR, Green PHR, Blaser MJ, Ludvigsson JF.
    Am J Gastroenterol; 2017 Dec; 112(12):1878-1884. PubMed ID: 29087398
    [Abstract] [Full Text] [Related]

  • 8. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL.
    World J Gastroenterol; 2015 Jun 07; 21(21):6728-35. PubMed ID: 26074711
    [Abstract] [Full Text] [Related]

  • 9. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE.
    Am J Gastroenterol; 2016 Nov 07; 111(11):1641-1648. PubMed ID: 27575714
    [Abstract] [Full Text] [Related]

  • 10. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA, Yu N, Lockhart MC, McGuigan CC, Wiuff C, Davey PG, Donnan PT.
    J Antimicrob Chemother; 2013 Dec 07; 68(12):2927-33. PubMed ID: 23825381
    [Abstract] [Full Text] [Related]

  • 11. Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients.
    Li GJ, Trac J, Husain S, Famure O, Li Y, Kim SJ.
    Transplantation; 2018 Sep 07; 102(9):1576-1581. PubMed ID: 29620613
    [Abstract] [Full Text] [Related]

  • 12. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K, Kopf D, Rösler A.
    BMC Geriatr; 2016 Nov 15; 16(1):185. PubMed ID: 27846818
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of Clostridium difficile infection in Portugal: Experience at a tertiary care hospital.
    Sintra S, Taveira F, Canha C, Carvalho A, Simão A.
    Eur J Intern Med; 2019 Feb 15; 60():e11-e13. PubMed ID: 30343987
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.
    Carignan A, Poulin S, Martin P, Labbé AC, Valiquette L, Al-Bachari H, Montpetit LP, Pépin J.
    Am J Gastroenterol; 2016 Dec 15; 111(12):1834-1840. PubMed ID: 27619835
    [Abstract] [Full Text] [Related]

  • 15. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S, Johnson S, Burns SP, Kralovic SM, Goldstein B, Smith B, Gerding DN, Evans CT.
    Am J Infect Control; 2014 Feb 15; 42(2):168-73. PubMed ID: 24485372
    [Abstract] [Full Text] [Related]

  • 16. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA.
    Arch Intern Med; 2010 May 10; 170(9):772-8. PubMed ID: 20458084
    [Abstract] [Full Text] [Related]

  • 17. High risk of Clostridium difficile infection among spinal cord injured patients after the use of antibiotics commonly used to treat urinary tract infections.
    Liu B, Reid J, Silverman M, Welk B.
    Neurourol Urodyn; 2020 Nov 10; 39(8):2401-2408. PubMed ID: 32902908
    [Abstract] [Full Text] [Related]

  • 18. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A, Pefanis A, Tsiodras S, Sipsas NV, Lelekis M, Lazanas MC, Gargalianos P, Dalekos GN, Roilides E, Samonis G, Maltezos E, Hatzigeorgiou D, Lada M, Metallidis S, Stoupis A, Chrysos G, Karnesis L, Symbardi S, Loupa CV, Giamarellou H, Kioumis I, Sambatakou H, Tsianos E, Kotsopoulou M, Georgopali A, Liakou K, Perlorentzou S, Levidiotou S, Giotsa-Toutouza M, Tsorlini-Christoforidou H, Karaiskos I, Kouppari G, Trikka-Graphakos E, Ntrivala MA, Themeli-Digalaki K, Pangalis A, Kachrimanidou M, Martsoukou M, Karapsias S, Panopoulou M, Maraki S, Orfanou A, Petinaki E, Orfanidou M, Baka V, Stylianakis A, Spiliopoulou I, Smilakou S, Zerva L, Vogiatzakis E, Belesiotou E, Gogos CA.
    PLoS One; 2017 Nov 10; 12(8):e0182799. PubMed ID: 28813492
    [Abstract] [Full Text] [Related]

  • 19. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T, Van Matre AG, Miller MA, Mueller SW, Bajrovic V, Abidi MZ, Benamu E, Kaiser JN, Barber GR, Chase S, Tobin J, Fish DN, Gutman JA.
    Biol Blood Marrow Transplant; 2019 Oct 10; 25(10):2091-2097. PubMed ID: 31255741
    [Abstract] [Full Text] [Related]

  • 20. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW.
    Clin Infect Dis; 2012 Oct 10; 55(8):1056-63. PubMed ID: 22784871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.